P10, Inc. (PX) Q3 2025 Earnings Call Transcript
P10, Inc. ( PX ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Mark Hood - Executive VP of Operations & Chief Administrative Officer Luke A. Sarsfield - Chairman of the Board, President & CEO Amanda Coussens - Executive VP & CFO Conference Call Participants Michael Cyprys - Morgan Stanley, Research Division Benjamin Budish - Barclays Bank PLC, Research Division Presentation Operator Hello, and welcome to the P10 Third Quarter 2025 Conference Call.
How Much Upside is Left in P10 (PX)? Wall Street Analysts Think 46.5%
The consensus price target hints at a 46.5% upside potential for P10 (PX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Compared to Estimates, P10 (PX) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for P10 (PX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
P10, Inc. (PX) Q2 2025 Earnings Call Transcript
P10, Inc. (NYSE:PX ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Amanda Nethery Coussens - Executive VP & CFO Luke A. Sarsfield - Chairman of the Board, President & CEO Mark C.
P10 (PX) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for P10 (PX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
P10, Inc. (PX) Surpasses Q2 Earnings and Revenue Estimates
P10, Inc. (PX) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.24 per share a year ago.
P10, Inc. Q1 Earnings: Small Alternative Investments Manager Getting Started
I rate P10, Inc. stock a Sell for long-term capital appreciation investors due to weak earnings and underperformance versus sector benchmarks. Q1 2025 results showed minimal revenue growth, declining profits, and a modest dividend increase that does little for income-focused investors. PX underperforms peers in total return and dividend yield, while trading at a premium valuation with no clear growth catalysts ahead.
P10, Inc. (PX) Q1 2025 Earnings Call Transcript
P10, Inc. (NYSE:PX ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Mark Hood - Executive Vice President & Chief Administrative Officer Luke Sarsfield - Chairman & Chief Executive Officer Amanda Coussens - Executive Vice President & Chief Financial Officer Sarita Jairath - Executive Vice President, Global Head of Client Solutions Conference Call Participants Chris Kotowski - Oppenheimer & Co. Alex Bernstein - JPMorgan Stephanie Ma - Morgan Stanley. Ben Rubin - UBS Operator Hello, and welcome to the P10 First Quarter 2025 Conference Call.
P10 (PX) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for P10 (PX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
P10, Inc. (PX) Q1 Earnings and Revenues Miss Estimates
P10, Inc. (PX) came out with quarterly earnings of $0.20 per share, missing the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.
P10, Inc. (PX) Reports Next Week: What to Know Ahead of the Release
P10 (PX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P10 Q4 Earnings: Strong Fund Raising Momentum Expected To Continue (Rating Upgrade)
P10's Q4 results showed impressive FPAUM growth, while revenue benefitted from higher-than-expected catch-up fees. Management's ambitious $50 billion FPAUM target by the end of 2029 implies a 14% CAGR, which will be achieved through organic growth and acquisitions. At 12.9 times FCF, shares are valued at a large discount compared to relevant peers.
